Market Cap: $2.15B
MI
Maravai LifeSciences Holdings, Inc.
MRVI
NASDAQ (NASDAQ Global Select)USD
Market Cap: $2.15B
TriLink BioTechnologies Expands mRNA Capabilities Through Strategic Partnership with Aldevron TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, has entered into a significant non-exclusiv…
TriLink BioTechnologies Partners with Avantor to Enhance Nucleic Acid Product Accessibility TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, announces a strategic partnership with Avanto…
Maravai LifeSciences Enhances Distribution of Nucleic Acid Products in EMEA Maravai LifeSciences Holdings, through its subsidiary TriLink BioTechnologies, has formed a strategic partnership with Avant…
TriLink BioTechnologies Partners with Avantor to Enhance EMEA Distribution TriLink BioTechnologies, a subsidiary of Maravai LifeSciences, announces a strategic partnership with Avantor, Inc. to bolste…
Maravai LifeSciences Expands Capabilities with Acquisition of Molecular Assemblies' IP Maravai LifeSciences, Inc. has made a significant advance in its mission to enhance life science reagents and ser…
Maravai LifeSciences Expands Capabilities Through Acquisition of Officinae Bio Maravai LifeSciences, Inc. has recently announced a strategic acquisition that positions the company to enhance its capab…
Maravai LifeSciences Strengthens Its Biotech Capabilities with Officinae Bio Acquisition Maravai LifeSciences, Inc. has announced a strategic acquisition of Officinae Bio's DNA and RNA operations, aim…